Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial

JM. Gutierrez, 2017, Snakebite envenoming, 3, 17063

2010, Guidelines for the prevention and clinical management of snakebite in Africa

RDG. Theakston, 2000, Crisis in snake antivenom supply for Africa, Vol. 356, 2104

DA. Warrell, 2008, Unscrupulous marketing of snake bit antivenoms in Africa and Papua New Guinea: chosing the right product–‘what’s in a name?’, 102, 397

DJ. Williams, 2019, Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming, Vol. 13, e0007059

E. Alirol, 2015, Antivenoms for snakebite envenoming: what is in the research pipeline?, Vol. 9, e0003896

J-P. Chippaux, 2010, Methodology of clinical studies dealing with the treatment of envenomation, Vol. 55, 1195

NI Brown, 2010, Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context, Vol. 6, e1670

Micropharm (2018), Micropharm press release. 2nd January 2018.

IS. Abubakar, 2010, Randomised Controlled Double-Blind Non-Inferiority Trial of Two Antivenoms for Saw-Scaled or Carpet Viper (<italic>Echis ocellatus</italic>) Envenoming in Nigeria, Vol. 4, e767

M. Coldiron, 2017, Utilisation des antivenins pour la prise en charge de morsure de serpent

AG. Habib, 2011, Factors affecting snakebite mortality in north-eastern Nigeria, Vol. 3, 50

JP. Chippaux, 1999, Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon, Vol. 61, 1017

LE. Visser, 2008, Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance, Vol. 102, 445

ER. Bregani, 2006, Snake bites in South Chad. Comparison between three different polyvalent anti-snake venom immunotherapies, Vol. 11, 25

J. Potet, 2015, Utilisation de Fav-Afrique et d’Antivipmyn-Africa contre les envenimations ophidiennes à Paoua, en République Centrafricaine

A. Benois, 2008, Efficacité et tolérance du sérum FAV-Afrique apres envenimation par <italic>Echis Pyramidum</italic>, Medecine Tropicale, Vol. 68, 411

Larreche, S. (2007), Les envenimations par viperides en republique de Djibouti D’octobre 1994 a Mai 2006: etude retrospective dans le Service de Reanimation du Groupement Medico-Chirurgical Bouffard. These: Docteur en Medecine. Universite Paris Val-De-Marne, Faculte De Medecine De Creteil

S. Larreche, 2018, Thromboelastographic study of the snakebite-related coagulopathy in Djibouti, Vol. 29, 196

FO. Ademola-Majekodunmi, 2012, Incidence of snakebites in Kaltungo, Gombe State and the efficacy of a new highly purified monovalent antivenom in treating Snakebite patients from January 2009 to December 2010, Vol. 105, 175

J-P. Chippaux, 2007, Clinical trial of an F(ab&apos;)2 polyvalent equine antivenom for African snake bites in Benin, Vol. 77, 538

MC. Balde, 2012, Étude clinique de la tolérance et de l’efficacité d’un sérum anti-ophidien polyvalent F(ab′)2 pour l’Afrique à Kindia, Guinée, Vol. 105, 157

MC. Balde, 2013, Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa, 19, 6

J-P. Chippaux, 2015, Évaluation d’un nouvel antivenin polyvalent contre les envenimations ophidiennes (Inoserp Panafricain) dans deux contextes épidémiologiques: le Nord Bénin et la Guinée Maritime, Vol. 25, 56

A. Lam, 2019, Évaluation de l’efficacité et la tolérance de Inoserp Panafricain au Sénégal, Vol. 31, 18

R. Blaylock, 2004, Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa, Vol. 43, 159

NF. Moran, 1998, High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom, Vol. 92, 69

D. Wood, 2009, Severe snakebites in northern KwaZulu-Natal: treatment modalities and outcomes, Vol. 99, 814

VM. Yates, 2010, Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania, Vol. 104, 439

SL. McNally, 1987, Victims of snakebite: a 5-year study at Shongwe Hospital, Kangwanem 1978–1982, Vol. 72, 855

D. Wilkinson, 1994, Retrospective analysis of snakebite at a rural hospital in Zululand, Vol. 84, 844

C. Swinson, 1976, Control of antivenom treatment in Echis carinatus (Carpet Viper) poisoning, Vol. 70, 85

DA. Warrell, 1977, Poisoning by bites of the Saw-Scaled or Carpet Viper (<italic>Echis Carinatus</italic>) in Nigeria, Quarterly Journal of Medicine, Vol. 181, 33

DA. Warrell, 1974, Bites by the Saw-scaled or Carpet Viper (<italic>Echic Carinatus</italic>): Trial of two specific antivenoms, 4, 437

D. Mekonnen, 2016, Snake bite: Case series of patients presented to Gondar University Hospital, North West Ethiopia, Vol. 54, 83

AG. Habib, 2015, Snakebite is Under Appreciated: Appraisal of Burden from West Africa, Vol. 9, e0004088